Search

Diagnostic ultrasound imaging is playing a more important role in medical technology and the medical supplies industry, and equipment replacement by hospitals should help revitalize the sector. Asia and Latin America are also emerging as important markets for ultrasound equipment due to its low cost and ability to reduce healthcare expenses. There are good earnings prospects for the industry and investors should seek the more timely stocks.

The US government is planning to make some major changes for managed care and Medicare recipients beginning in Nov 1998 and this will have an effect on provider cost controls. Medical supply manufacturers, especially the orthopedic sector, will be affected by this, but new products will aid sales and margins in 1998 and through the years 2001-2003. Investors, however, should select the most timely stocks for commitment.

Diabetes has become more prevalent in the US, and the world at large, with the ageing of the US population and other factors. The market for diabetes and glucose test equipment, as well as insulin therapy needs, has become more important to medical supplies companies, such as Johnson and Johnson and Abbot Labs. Cost controls and new products have combined for good 1998 profit prospects for the industry, and investors should seek timely stocks.

There have been efforts by the Food and Drug Administration in the US and similar agencies in Europe for workload reduction, fewer demands on medical supply companies, and other forms of regulatory reform. There have also been drug and diagnosis innovations which will personalize medical care, and heart disease has been targeted for greater health care spending. Investors need to select stocks in this industry on an individual timeliness basis.

Medical supply stocks are not expected to do well in 1997 because of the proposed Medicare budget and some collaborations among companies. Those stocks that are expected to do well can be invested in to diversify a portfolio that is strong in favorable investment stocks. Some medical supply stocks will not increase their earnings in 1997 and 1998 because of the value of the US dollar against foreign currencies.

The medical supplies industry as a whole appears to have a bright future but since the industry is large and varies in products produced, investors should check Safety and Timeliness ratings for individual companies to avoid risks. New products will be the key to increased sales, but since these require additional research and development costs and are often delayed by government regulations, the beneficial results are often slow in coming.

The medical supplies industry has always depended upon technological advancements but it is necessary for the benefits of new medical instruments to be worth more than the costs. The cyclical nature of the industry does not preclude that there are stocks that will interest investors. It is necessary to study their value and it may not be wise to hold on to them until the year 2000.

Medical supplies sales in the next three to five years are expected to increase through the late 1990s with new product introductions, along with reforms in FDA product review. Lower capital expenditures by hospitals and new outpatient treatment facilities will have an impact on medical supplies sales as well. Industry earnings for 1996 and 1997 are expected to be good, and these stocks should outperform the market.

Potential investors in the medical supplies industry should be cautious and carefully check individual Timeliness and Safety rankings. Although the industry is attracting interest with double-digit earnings growth in some cases, it will be affected by the effects of information technology and the potential restructuring of the FDA merit watching system. Consolidation is likely in the manufacturing sector.

There was further consolidation in the medical supplies industry in 1995, especially in the interventional cardiology field. Revenues and earnings for the industry have also been strong in 1995. There will be increased demand for medical supplies and services in 1996 with improved living standards and the aging population worldwide, which will benefit profit margins. There are a wide variety of timely stocks in this industry for investor selection.

DUBLIN, Ohio -- Set aside the big merger prospects for a moment. Cardinal Health in its own right enjoyed a robust fiscal 1997. It posted 54 percent gains in net [...]